Search over 3,000 reports

    Tafinlar - API Insights, 2017

    Tafinlar - API Insights, 2017
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 30
    Geography: Global
    Delivery Timeline: 48 Hours
    SKU: DIDA0171
    DelveInsight's, Tafinlar - API Insights, 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to the Tafinlar. The report also highlights the patent details of Tafinlar.
    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
    Evaluate the marketing status of Tafinlar to exploit opportunities for generic Tafinlar development opportunities
    Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Tafinlar
    API intelligence over Tafinlar and gaining primary intelligence over Active Ingredient manufacturers by country
    Make more informed business decisions from insightful and in-depth analysis of the Tafinlar's performance
    Tafinlar Overview
    Tafinlar Global Sales Assessment
    Tafinlar Historical Global Sales
    Tafinlar Forecasted Global Sales
    Product Description
    Mechanism of Action
    Pharmacodynamic Properties
    Pharmacokinetic Properties
    Product Details by country
    Patent Information
    Global API Manufacturers Assessment
    Active Pharmaceutical Ingredient (API) Manufacturers by Country
    Active Pharmaceutical Ingredient (API) Manufacturers by Region
    Consulting Services
    About DelveInsight
    Table 1: Tafinlar Historical Global Sales from 2009-2016 (in million USD)
    Table 2: Tafinlar Forecasted Global Sales from 2017-2022 (in million USD)
    Table 3: Tafinlar General Description
    Table 4: Product Details by country
    Table 5: Patent Information
    Table6: API Manufacturers by country
    Table 7: API Manufacturers by Region
    Figure 1: Tafinlar Historical Global Sales from 2009-2016 (in million USD)
    Figure 2: Tafinlar Forecasted Global Sales from 2017-2022 (in million USD)
    Figure 3: Tafinlar Patent Details
    Figure 4: Tafinlar API Manufacturers by Country
    Figure 5: Tafinlar API Manufacturers by Region
    unresectable or metastatic melanoma; BRAF V600E or V600K mutation
    Tafinlar Marketed Drugs Overview
    Tafinlar Market Assessment
    Tafinlar API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
    Tafinlar US DMF
    Tafinlar US Drug Master Files
    Tafinlar Active Substance Master File/ EUDMF
    Tafinlar Generic players
    Tafinlar Patent Expiration
    Tafinlar Patent Exclusivity
    Tafinlar API Manufacturers
    Tafinlar Global Forecasted Sales Figure
    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap